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http:WHAT THIS PAPER ADDS
This study demonstrates that systematic pre-operative coronary angiography, followed by selective myocardial
revascularization prior to carotid endarterectomy (CEA), reduces the incidence of late myocardial infarction and
increases the survival rate in patients without any previous history of coronary artery disease. Therefore in the
future, routine coronary screening should be considered as part of the standard pre-operative cardiac workup
for CEA candidates. In addition, considering not only the potential risk of myocardial infarction in these patients
but also the opportunity cost entailed, a possibly less invasive screening test with pre-operative thallium
scanning or coronary CT should be thoroughly investigated.Objectives: To evaluate the potential beneﬁt of systematic preoperative coronary-artery angiography followed by
selective coronary-artery revascularization on the incidence of myocardial infarction (MI) in patients undergoing
carotid endarterectomy (CEA) without a previous history of coronary artery disease (CAD).
Methods: We randomised 426 patients who were candidates for CEA, with no history of CAD, a normal
electrocardiogram (ECG), and a normal cardiac ultrasound. In group A (n ¼ 216) all patients underwent coronary
angiography before CEA. In group B (n ¼ 210) CEA was performed without coronary angiography. Patients were
not blinded for relevant assessments during follow-up. Primary end-point was the occurrence of MI at 3.5 years.
The secondary end-point was the overall survival rate. Median length of follow-up was 6.2 years.
Results: In group A, coronary angiography revealed signiﬁcant coronary artery stenosis in 68 patients (31.5%).
Among them, 66 underwent percutaneous Intervention (PCI) prior to CEA and 2 received combined CEA and
coronary-artery bypass grafting (CABG). Postoperatively, no MI was observed in group A, whereas 6 MI occurred
in group B, one of which was fatal (p ¼ .01).
During the study period, 3 MI occurred in group A (1.4%) and 33 were observed in group B (15.7%), 6 of which
were fatal. The Cox model demonstrated a reduced risk of MI for patients in group A receiving coronary
angiography (HR,.078; 95% CI, 0.024-0.256; p < .001). In addition, patients with diabetes and patients <70 years
presented with an increased risk of MI. Survival analysis at 6 years by Kaplan-Meier estimates was 95.6  3.2% in
Group A and 89.7  3.7% in group B (Log Rank ¼ 6.54, p ¼ .01).
Conclusions: In asymptomatic coronary-artery patients, systematic coronary angiography prior to CEA followed
by selective PCI or CABG signiﬁcantly reduces the incidence of late MI and increases long-term survival.
(ClinicalTrials.gov number, NCT02260453).
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The prevalence of coronary artery disease (CAD) among
patients undergoing elective vascular surgery has been re-
ported to be between 46% and 71%1,2 with post-operative
coronary complications observed in around 20% of cases3
and an incidence of cardiac death at 1 year between 6 to
10%.4e7 In addition, a large retrospective study8 has shown
that coronary artery bypass grafting (CABG) before periph-
eral vascular surgery improves long-term outcomes.
Panels of experts have recommended CABG before pe-
ripheral vascular surgery in patients with unstable angina for
whom CABG offers long-term survival beneﬁt.9 But despite
the existence of consensus guidelines, the optimal strategy for
pre-operative cardiac risk management among patients
scheduled for peripheral vascular surgery remains controver-
sial with the likelihood of discordance between two cardiol-
ogists around 54%, and a 26% chance that recommendations
for coronary revascularization will be directly contradictory.10
While some studies have demonstrated the efﬁcacy of coro-
nary angiography or thallium scanning followed by selective
coronary revascularization in the prevention of post-operative
myocardial ischemia,11e13 other studies have not only failed
to show any substantial beneﬁt but also raised concern about
the riskof peri-operative bleeding in conjunctionwith the dual
antiplatelet regimen required after pre-operative percuta-
neous intervention (PCI).14e16
In a previous data analysis, it was demonstrated that
systematic pre-operative angiography, followed by selective
coronary revascularization, signiﬁcantly reduced the inci-
dence of post-operative MI after carotid endarterectomy
(CEA) in patients without clinical evidence of CAD.17 We are
reporting in the present study, the long-term follow up of
this trial to assess whether the systematic use of pre-
operative coronary angiography followed by selective cor-
onary artery revascularization signiﬁcantly reduces occur-
rence of late MI and improves survival in patients without a
previous history of CAD at the time of carotid surgery.
MATERIAL AND METHODS
Study design
This randomized controlled trial (RCT) was conducted be-
tween January 2005 and December 2008 at two academic
surgical centers and one afﬁliated surgical service. 426 pa-
tients were enrolled in the study. Among them, 216 were
randomized to undergo pre-operative coronary angiography
(group A) prior to CEA, and 210 underwent CEA without
prior coronary angiography (group B) The trial was registered
(ClinicalTrials.gov number, NCT02260453) and supported by
a grant from the University of Rome. The institutional review
board of the University approved the trial protocol and all
patients provided written informed consent.Randomization
Random assignment of patients to the two treatment
groups was done independently of participating centers in a
one to one ratio. The randomization sequence wasgenerated by a computer program and centralized. The time
of randomization was considered as time 0.
Eligibility criteria
The indication for CEA included carotid artery stenosis >
60% according to the NASCET criteria.18 As previously re-
ported,17 patients referred for CEA were enrolled in the
study if they had no evidence of CAD, deﬁned as the absence
of any clinical sign or history of ischaemic cardiac disease, no
electrical signs of cardiac ischemia at rest and a left ven-
tricular ejection fraction > 50% on transthoracic echocar-
diogram. In order to measure functional capacity (METS-
metabolic equivalent), the cardiologists included a ques-
tionnaire on physical activity following the International
Physical Activity Questionnaire (IPQ), the Physical Activity
Scale for the Elderly (PASE), and the Metabolic Equivalent
Task Scale (METS) with careful investigation of any clinical
metabolic impairment before randomization. The items
included were (a) classiﬁcation of effort dyspnea during daily
activity, (b) cycling (if adequate), (c) climbing a ﬂight of stairs,
(d) walking 4 mph, (e) yard work and other physical activity
corresponding to a functional capacity classiﬁcation of 4e7
METS. All patients presenting with doubtful clinical status
and a functional capacity below 4 METS despite a normal left
ventricular ejection fraction (LVEF) were excluded from
randomization and received a complete coronary workup.
Randomized patients had a median METS of 5.8 (4.5e7.6).
In addition, the initial METS classes of patients with positive
coronary angiography in group A or without coronary angi-
ography (group B) but presenting with a MI during follow up
were not different from those of patients with negative cor-
onary angiography and/or uneventful coronary follow up. As
shown in the CONSORT ﬂowchart (Fig. 1) patients were ran-
domized in two groups. In group A, coronary artery stenosis
was considered signiﬁcant if > 75% in diameter reduction as
seen on coronary angiography, with the help of intravascular
ultrasound in nine doubtful cases. Signiﬁcant stenosis was
treated either by PCI or by CABG according to current treat-
ment standards. After coronary angiography and PCI all pa-
tients had ECGmonitoring and their serum troponin level was
assessed at 4, 8, 12, and 24 hours after the procedure. Peri-
procedural MI was deﬁned as electrical changes associated
with rise of troponin levels (Table 1). In group B (n ¼ 210)
patients received CEA without any further cardiac evaluation.
Study endpoint
The primary endpoint of the study was the occurrence of MI
at 3.5 years. The secondary endpoint was overall survival and
freedom from stroke, along with any complication related to
coronary angiography and PCI. These endpoints were eval-
uated at 30 days and at 6 years from randomization.
Sample size
As previously reported in the CARP (Coronary Artery
Revascularization Prophylaxis) trial,3 MI was observed in
approximately 20% of patients after major peripheral
vascular surgery. In this study two groups of > 200 patients
Figure 1. CONSORT ﬂow chart of the study. 688 patients were assessed for eligibility and 426 were randomized in the study (62%). 216
patients were allocated to group A and received CA before CEA. In group B, 210 patients were allocated to CEA without CA. There was no
crossover. In group A, 68 patients presented with signiﬁcant coronary artery disease and received coronary revascularization before CEA.
CA ¼ coronary angiography; CAD ¼ coronary artery disease; CEA ¼ carotid endarterectomy.
368 G. Illuminati et al.were enrolled with the hypothesis of a MI reduction rate of
10% in the group with systematic coronary angiography at
3.5 years. With its sample consisting in 400 patients, the
study had a 80% power to detect differences in the 3.5 year
rates for MI of 20% in one group and 10% in the other
group at a signiﬁcance level < .05.Table 1. Deﬁnitions.
Myocardial
infarction
Acute myocardial infarction (MI) was deﬁned by a
percentile upper reference limit and with at least
(1) New signiﬁcant ST segment T-wave (ST-T) chan
(2) Development of pathological Q waves in the E
(3) Imaging evidence of new loss of viable myocar
identiﬁcation of an intra-coronary thrombus by
related myocardial infarction was arbitrarily de
(>5  99th percentile) in patients with norma
if the baseline values are elevated.
During follow up, if the patient was seen at a dist
meets the diagnosis for prior myocardial infarction
(i) pathological Q waves with or without symptom
(ii) imaging evidence of a region of loss of viable
Cerebrovascular
accident
Any new episode of transient ischemic attack or sOutcomes
The study was conducted between January 2005 and
December 2008. After PCI, patients in group A underwent
CEA under dual oral antiplatelet regimen consisting of
100 mg/day aspirin and 75 mg/day clopidogrel. Patientsrise of cardiac troponin with at least one value above the 99th
one of the following:
ges or new left bundle branch block (LBBB)
CG
dium or new regional wall motion abnormality, including
angiography or autopsy. Percutaneous coronary intervention
ﬁned by elevation of cardiac troponin values
l baseline values or a rise of cardiac troponin values >20%
ance from the acute onset, any of the following criteria
:
s in the absence of non-ischemic causes
myocardium
troke
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CABG and received low molecular weight heparin during
the peri-operative period. The remaining patients without
PCI or CABG underwent CEA under single oral antiplatelet
regimen consisting of 100 mg/day oral aspirin. All patients
in both groups received 40 mg/day oral atorvastatin,
beginning one week before CEA. In addition, 141 patients
(65%) in group A, and 152 patients (72%) in group B
received beta blockers for the treatment of hypertension,
which was deﬁned as a composite variable including blood
pressure values, history of hypertension, and speciﬁc
medications given for this indication. Hyperlipidemia was
deﬁned according to the National Cholesterol Education
Program Adult Treatment Panel (NCEP ATP III) guidelines, as
cholesterol level > 240 mg/dL and/or triglyceride level >
150 mg/dL. At discharge from hospital, in order to eliminate
any possible bias related to speciﬁc medical treatment, all
patients, irrespective of whether or not they were treated
by PCI, received a life-long, dual, oral daily antiplatelet
regimen consisting of 100 mg of aspirin and 75 mg of clo-
pidogrel. Atorvastatin (40 mg/day) was likewise prescribed
to all patients, whereas beta blockers were conﬁrmed in
65% of the patients in group A, and in 72% of the patientsTable 2. Characteristics of patients randomized to systematic
coronary angiography prior to carotid endarterectomy in group A
or direct CEA in group B.
Baseline characteristics Group A
N ¼ 216
Group B
N ¼ 210
p value
Age, years  SD 77  7 74  7 .79
Men (%) 140 (65) 143 (68) .60
Hypertension (%) 164 (76) 168 (80) .90
Active smokers (%) 86 (40) 90 (43) .62
Hyperlipidemia (%) 63 (29) 55 (26) .52
Diabetes (%) 52 (24) 46 (22) .73
Lower limb occlusive disease (%) 22 (10) 17 (8) .40
Chronic renal insufﬁciency (%) 9 (4) 10 (5) .82
CADa in Group A
1-vessel disease (%) 43 (20)
2-vessel disease (%) 19 (9)
3-vessel disease (%) 3 (1.5)
Left main disease (%) 3 (1.5)
Indications for carotid surgery
Asymptomatic 157 (72) 151 (71)
TIA & Stroke 59 (28) 59 (28) .56
Operative technique
CEA with patch closure 177 (82) 176 (84)
CEA by eversion 39 (18) 34 (16) .76
Carotid Shunt 26 (12) 19 (9) .27
Duration (minutes  SD) 126  42 112  36 .82
Characteristics of patients in Group A with preoperative coronary
angiography prior to carotid surgery and in Group B without
coronary angiography prior to carotid surgery.
CEA: carotid endarterectomy, SD: standard deviation.
a CAD: Coronary Artery Disease, lesions seen at systematic coro-
nary angiography in 68 patients of Group A. These lesions were
treated before carotid surgery by coronary angioplasty and
stenting (PCI) in 66 patients and by coronary artery bypass grafting
(CABG) in 2 patients.in group B. Characteristics of the patients, indications for
CEA, and details of the previously reported surgical tech-
nique17 are summarized in Table 2. Among the 216 patients
in group A, 68 patients (38.5%) had asymptomatic signiﬁ-
cant stenosis of the coronary arteries and 66 underwent
PCI, 1e8 days prior to CEA, whereas two patients under-
went combined CEA and CABG.
Post-operatively and during follow up the diagnosis of MI
was conﬁrmed by the occurrence of speciﬁc abnormalities on
the ECG that were consistent with myocardial ischemia
associated with signiﬁcant elevation of serum troponin level.
The diagnosis was eventually further conﬁrmed by thallium
myocardial scanning and/or coronary angiography. Neither
electrical changes alone,without elevation of serum troponin
level, nor isolated serum troponin elevation without MI
related speciﬁc ECG changes, was considered sufﬁcient for
the diagnosis of MI. Myocardial related mortality were
deﬁned as any death related toMI collected from themedical
records according to the above mentioned deﬁnitions. In
case of post-operative death, in addition to the electrical
changes coupled with serum troponin levels, diagnosis was
conﬁrmed at post mortem examination in all cases.
Follow up
Patients were examined in the outpatient clinic every 6
months with a duplex ultrasound of the vessels to the head
so as to assess the patency of the carotid revascularization
and the status of the contralateral internal carotid artery.
Compliance with statin therapy with lipidemia control,
smoking cessation and blood pressure control were similarly
assessed at this time, and continued to be assessed by the
caring physician and cardiologists. Close surveillance of the
patients’ pillboxes was maintained so as to be sure that they
were actually taking their prescribed medicine. This was
made possible with the help of the family doctor, who
received a summary of the study and a form to ﬁll out
regarding compliance with the medical treatment. In paral-
lel, a coronary evaluation was carried out and all symptoms
of coronary artery disease were recorded. Medical records of
intercurrent hospitalization for any cause were also analyzed.
When patients missed the scheduled follow up appoint-
ments, relevant information was gathered through ex-
changes with relatives, caring physicians and cardiologists.
Median follow up was 6.2 years (95% CI, 6.1e6.3 years).
Statistical methods
Descriptive statistics were calculated using two sided t tests,
while chi-square (Pearson and Fisher) tests evaluated dif-
ferences in patient demographics and co-morbidities be-
tween treatment groups. Since the incidence of MI from
non-signiﬁcant coronary artery stenoses has been esti-
mated to be 11.6% at 3.5 years,19 a follow up period of 3e6
years was taken into consideration. Intention to treat
analysis provided information about survival from the time
of randomization. Survival curves were generated with the
KaplaneMeier product limit estimates and intergroup dif-
ferences were evaluated by the log-rank test. The Cox
370 G. Illuminati et al.proportional hazards model was used to calculate estimates
of relative risk (hazard ratio [HR]) and 95% conﬁdence in-
terval (CI) comparing groups A and B controlling for nine
independent variables (age, sex, hyperlipidemia, diabetes,
hypertension, peripheral occlusive arterial disease, smoking,
previous cerebrovascular accidents, and coronary angiog-
raphy). Partial likelihood ratio test was used to ﬁt the best
model for multivariable Cox regression analysis. All statis-
tical analyses were carried out using SPSS v.22 (IBM cor-
poration). Statistical signiﬁcance was deﬁned as p < .05.
RESULTS
Primary endpoint: hazard ratio for myocardial infarction
Cox proportional hazard model was performed to assess the
impact of a number of factors on the likelihood of patients
presenting an MI (Table 3). The Cox model demonstrated a
signiﬁcant trend towards reduced risk of MI for patients in
group A receiving a pre-operative coronary angiogram
compared to those in group B who were operated on
without coronary angiography (HR, 078; 95% CI, 0.024e
0.256; p < .001). In addition, patients with diabetes and
patients aged less than 70 years presented with an
increased risk of MI with an HR of 2.86 (95% CI, 1.46e5.60;
p ¼ .002) for diabetics versus non-diabetics and an HR of
4.02 (95% CI, 2.03e7.98; p < .001) for patients aged less
than 70 years versus older patients (Fig. 2).
During the study period, three MIs (2 non-STEMI, 1
STEMI) occurred in group A (1.4%), and 33 MI (18 non-
STEMI, 15 STEMI) in group B (15.7%; p < .001). No MI
was observed within 30 days of CEA in group A versus 9 MIs
of which one was fatal in group B (p ¼ .01). In group A, all
three MIs were delayed at 22, 59, and 63 months after
randomization, one MI was due to restenosis of a PCI per-
formed before CEA, and two MIs occurred in patients who
presented a non-signiﬁcant coronary artery stenosis at the
time of CEA. None of these three late MIs was fatal, and
related coronary artery lesions were treated by PCI.Table 3. Factors associated with cardiac ischemic events. Results of C
B SE Wa
Coronary angiography vs. none 2.550 0.607 17.6
Age <70 years vs. age 70 years 1.393 0.349 15.8
Diabetes vs. none 1.051 0.343 9.3
Female vs. male 0.025 0.368 0.0
Hyperlipidemia vs. none 0.086 0.399 0.0
Cerebrovascular event vs. none 0.047 0.374 0.0
Hypertension vs. none 0.253 0.454 0.3
PAOD vs. none 0.406 0.501 0.6
Smoking history vs. none 0.332 0.340 0.9
Note. Cerebrovascular event is any transient ischemic attack or any st
arterial disease; CI ¼ conﬁdence interval; SE ¼ standard error of B.
a Cox proportional hazard model: Cardiac ischemic event (MI) serves a
the event deﬁned by the dependent variable and covariates (indepen
category. As part of the logistic regression model provided by SPSS,
likelihood value of 431.10 and a chi-square value of 60.31, which is st
covariates signiﬁcantly affects the probability of occurrence of MI. Amon
coronary angiography was the only variable to signiﬁcantly decrease th
diabetes signiﬁcantly increase this risk.Overall, 33 MIs were observed in group B (15.7%) of
which six were fatal, while the other 27 were managed by
either PCI (n ¼ 18), CABG (n ¼ 2), or medical treatment
alone due to non-reconstructible CAD (n ¼ 7).
Compliance was assessed for the statin and dual anti-
platelet regimens and was comparable in both groups. For
statins, at 6 year follow up compliance was 84% (n ¼ 136) in
group A vs. 81% (n ¼ 129) in group B, (p ¼ .88). For dual
antiplatelet regimens, compliance was 78% (n ¼ 130) in
group A vs. 82% (n ¼ 131) in group B, (p ¼ 0.41).Secondary endpoint: survival, stroke rate and coronary
angiography/PCI complications
The combined death and stroke rate at 30 days was 0.5% in
group A and 1.8% in group B (p ¼ .36). After a median
follow up of 6.2 years, 11 deaths occurred in group A (7
related to cancer, 1 to trauma, 2 to lung disease, and 1 of
unknown cause), and 24 deaths in group B (6 related to MI,
14 to cancer, 3 to end-stage renal disease, and 1 to lung
disease). Among the six deaths due to MI, post mortem
conﬁrmation of the diagnosis was available for four. Sur-
vival at 6.1 years was 95.6  3.2% in group A and
89.7  3.7% in group B (Fig. 3). KaplaneMeier estimates
were used to generate survival curves and demonstrated
higher survival in group A than in group B (log-rank; chi-
square: 6.35, p ¼ .01). Mortality speciﬁcally related to
MI was also signiﬁcantly higher in group B (n ¼ 6/210) than
in group A (n ¼ 0/216) (p ¼ .01). No late stroke, either
ischaemic or hemorrhagic, was observed during follow up
in either group. No complication related to coronary
angiography or PCI, such as post-procedural MI or arterial
access complication or bleeding due to dual antiplatelet
treatment, either post-PCI or post-CEA, occurred during
the study period. No antiplatelet treatment related
gastrointestinal bleeding was observed or reported either
post-operatively or during follow up.ox proportional hazard model.a
ld test p Hazard ratio Hazard ratio (95% CI)
98 <.001 0.078 0.024e0.256
96 <.001 4.025 2.030e7.982
60 .002 2.859 1.459e5.605
05 .946 0.975 0.474e2.008
46 .830 0.918 0.420e2.005
16 .899 1.049 0.504e2.182
10 .578 1.287 0.529e3.132
56 .418 1.501 0.562e4.008
53 .329 1.393 0.716e2.710
roke; B ¼ the regression coefﬁcient; PAOD ¼ peripheral occlusive
s the dependent variable; a time variable assesses the duration of
dent categorical variables) with one level being used as reference
the Omnibus tests of model coefﬁcients leads off with a 2 log
atistically signiﬁcant (p < .001), indicating that this group of nine
g all the covariates that were analyzed in this model, pre-operative
e risk of MI with a HR of 0.078. Two covariates, age < 70 years and
Figure 2. A Cox regression model was used to analyze subgroups of
patients with characteristics indicating a high risk of myocardial
infarction. It showed that coronary artery angiography followed
eventually by coronary revascularization prior to CEA (A) did
impart a survival beneﬁt to the patients (HR, .078; 95% CI, 0.024e
0.256; p < .001) compared with those operated on without cor-
onary angiography. In addition, patients with diabetes (B) pre-
sented with an increased risk of MI with an HR of 2.86 (95% CI,
1.46e5.60; p ¼ .002) as patients < 70 years (C) with an HR of 4.02
(95% CI, 2.03e7.98; p < .001). CEA ¼ carotid endarterectomy;
HR ¼ hazard ratio; MI ¼ myocardial infarction.
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The present study presents an aggressive strategy of pro-
phylactic coronary angiography for patients who are can-
didates for CEA and suggests that systematic coronary
angiography prior to CEA, followed by selective PCI orCABG, signiﬁcantly lowers the occurrence of late MI and
improves late survival. As previously stated, there exist
disparate opinions regarding indications for coronary
revascularization before elective vascular surgery.10,20 A
comprehensive study of patients having undergone routine
coronary angiography before major vascular surgery
showed that 60% of these patients have one or more cor-
onary arteries with > 70% stenosis, including 18% with
severe triple vessel disease and 4% with left main disease.8
A recent study found that the prevalence of signiﬁcant
coronary artery disease was 56.8% in vascular surgery pa-
tients without cardiac complaints.21 However, systematic
pre-operative coronary angiography followed by selective
CABG prior to major vascular surgery is not free from po-
tential complications, and raises riskebeneﬁt issues. While
the CARP trial20 and the DECREASE-V study22 found no
beneﬁt of pre-operative coronary revascularization over
medical therapy before vascular surgery, they had some
signiﬁcant limitations.
The CARP trial3,20 screened 5,859 vascular surgery pa-
tients but randomized only 8.9% of them excluding those
with left main coronary artery disease. A re-analysis of the
trial found that patients who received complete coronary
revascularization had fewer post-operative MIs than those
who did not.23 In addition, pre-operative coronary revas-
cularization improved survival in patients presenting with
left main coronary artery stenosis (4.6%). In the CARP study,
however, this population was excluded from randomiza-
tion.24 The DECREASE-V trial22 randomized 101 vascular
surgery patients with severe CAD. In the revascularization
arm of this study, 100% of patients had a history of MI and
47% had congestive heart failure. Post-operative mortality
reached 22% despite coronary revascularization. The pop-
ulation consisted of patients with multiple small vessel
disease who were clearly too ill for CABG or who presented
with lesions not amenable to percutaneous coronary artery
revascularization. Furthermore, following DECREASE-V
investigation, not a single case record form could be
found for the 101 patients, and subsequent DECREASE
studies fell short of the standards routinely assumed by
clinical readers.25 The American Heart Association/Amer-
ican College of Cardiology guidelines published in 20029
recommended coronary angiography only when, after
positive non invasive testing, a patient was considered at
risk of peri-operative cardiac complications. Recently,
however, Monaco et al.26 demonstrated that a strategy of
routine pre-operative coronary angiography followed by
selective coronary revascularization provided better survival
and cardiovascular event free survival for vascular surgery
patients than a strategy of revascularization implemented
only after positive non-invasive testing. In addition, the
strategy of systematic coronary angiography for patients at
medium risk who are candidates for vascular surgery could
translate into more effective long-term secondary preven-
tion of coronary events with better adherence to lifelong
medical therapy.27
Previous studies have shown substantial improvement in
long-term survival in patients undergoing vascular surgery
Figure 3. Long-term survival among patients assigned to undergo coronary artery angiography (group A) or no coronary artery angiography
(group B) before carotid endarterectomy. KaplaneMeier estimates were used to generate survival curves from the time of randomization
for all study patients. The median survival was 6.2 years (95% CI, 6.1e6.3 years). Survival at 6 years was 95.6  3.2% in group A and
89.7  3.7% in group B, log-rank (chi-square: 6.35, p ¼ .01).
372 G. Illuminati et al.where pre-operative thallium scanning is followed by se-
lective coronary angiography and revascularization.28 How-
ever, thallium scanning may not be fully reliable as a
predictor of asymptomatic signiﬁcant coronary artery dis-
ease, especially in patients with left main or three vessel
disease who are most at risk of post-operative and long-
term MI.29 In a recent prospective study of coronary ar-
tery atherosclerosis, the incidence of new coronary
ischaemic events from non-signiﬁcant coronary artery ste-
noses was 11.6% at 3.4 years,19 a rate similar to the one
observed in group B. Frequently angiographically mild le-
sions were thin-cap ﬁbroatheromas or were characterized
by a large plaque burden, a small luminal area, or some
combination of these characteristics, as determined by
intravascular ultrasonography.
In the present study, the relatively high incidence of peri-
operative MI in group B (4.2%) can be explained by the
close monitoring of ECG and serum troponin levels for the
purposes of the trial, which allowed all subclinical MIs to be
detected. The study demonstrates that the strategy of
prophylactic coronary angiography for patients who are
candidates for CEA not only leads to a signiﬁcant reduction
of post-operative MI, but also favorably impacts the natural
history of coronary atherosclerosis by reducing the rate of
late ischemic events. Overall, this ﬁnding underscores the
impact of post-operative MI on short- and long-term sur-
vival after vascular surgery.30,31
One concern in this study was that coronary artery angi-
ography might lead to overtreatment of coronary artery le-
sions and unduly expose asymptomatic patients to
complications related to an invasive procedure. In this series,however, no myocardial infarction was observed as a conse-
quence of coronary angiography or revascularization and the
mild increase of cardiac biomarkers observed after PCI,
without clinical symptoms and/or ECG alterations, has been
shown not to be associated with an increased risk of death
and MI.32 Furthermore, no post-operative or late bleeding
related to dual antiplatelet treatment was noted in this study.
And yet, despite these favorable results, the use of both CEA
and PCI/CABG in an asymptomatic patient above 75 years of
age may appear unjustiﬁed and prohibitively costly. However,
in line with the 10 year results of the Asymptomatic Carotid
Surgery Trial,33,34 pre-operative coronary angiography fol-
lowed by optional PCI/CABG could further reduce peri-
operative and late MI including fatal ones as shown in this
study, helping to ensure better life expectancy and allowing
older patients with severe asymptomatic carotid artery ste-
nosis to beneﬁt from CEA for many years, thereby justifying
the additional costs associated with this policy.
In order to ﬁnd variables that could help to identify
subgroups of patients with severe carotid stenosis who
would be at higher risk of signiﬁcant asymptomatic CAD,
risk factors were entered in a Cox proportional hazards
regression, which demonstrated that diabetes and age < 70
years were associated with a higher risk of asymptomatic
CAD. As this subset of patients would be most likely to
beneﬁt from systematic pre-operative coronary angiog-
raphy, in the interests of cost-effectiveness it is suggested
that pre-operative coronary artery imaging should be
limited to them.
The use of a less invasive test such as pre-operative
thallium scanning or coronary CT-scan instead of coronary
Role of Preoperative Coronary Angiography in Patients with Carotid Endarterectomy 373angiography has also been considered. However, as shown
by Bursi et al.35 these investigations may not to be as
effective as standard coronary angiography as a means of
recognizing signiﬁcant CAD in asymptomatic patients.
Moreover, Back et al.36 have demonstrated that the pres-
ence of three vessel angiographic CAD was an independent
predictor of cardiac morbidity, whereas induced ischemia by
test imaging was not. Furthermore, among elderly people, a
negative and/or equivocal non-invasive stress test does not
necessarily exclude appreciable CAD involvement.37
Despite the potential impact of this study, some of its
limitations should be emphasized. First, the group receiving
coronary angiography and subsequent coronary revascu-
larization had a very low rate of complications. Secondly,
the rate of drug compliance exceeding 80% at 6 years for
statins, and dual antiplatelet regimes could limit the appli-
cability of the results in usual practice where higher surgical
risk and lower drug compliance is commonly reported. In
addition, generalization of these results should be limited to
patients with severe carotid stenosis undergoing surgery.
Finally, as the patients were unblinded, awareness of the
treatment assignment may have led to possible bias con-
cerning the diagnoses of potential MI occurring during
follow up that, except for post mortem examination, were
given by the cardiologists in charge of the patients and not
by independent observers. However, outcomes were
objectively assessed by all authors and analysis of the data
suggests no group difference in appropriateness of care or
reliability of the results.
CONCLUSIONS
This RCT has shown that systematic coronary angiography
followed by selective coronary revascularization before CEA
in patients with asymptomatic coronary artery disease was
safe and could improve long-term freedom from MI and
late survival. These ﬁndings from a relatively small RCT need
to be conﬁrmed by additional larger controlled studies. In
addition, considering the potential risk of MI in these pa-
tients but also the opportunity cost, a possibly less invasive
screening test with pre-operative thallium scanning or cor-
onary CT should be investigated.
FUNDING
This study was supported by a research grant (Prot.P 187/
07) from the University of Roma “La Sapienza”.
CONFLICT OF INTEREST
None.
ACKNOWLEDGEMENTS
The authors acknowledge the assistance of Mr Jeffrey
Robert Arsham with language editing of the article.REFERENCES
1 Sukhija R, Aronow WS, Yalamanchili K, Sinha N, Babu S. Prev-
alence of coronary artery disease, lower extremity peripheralarterial disease, and cerebrovascular disease in 110 men with
an abdominal aortic aneurysm. Am J Cardiol 2004;94:1358e9.
2 Dieter RS, Tomasson J, Gudjonsson T, Brown RL, Vitcenda M,
Einerson J, et al. Lower extremity peripheral arterial disease in
hospitalized patients with coronary artery disease. Vasc Med
2003;8:233e6.
3 McFalls EO, Ward HB, Moritz TE, Goldman S, Krupski WC,
Littooy F, et al. Coronary artery revascularization before elec-
tive major vascular surgery. N Engl J Med 2004;351:2795e804.
4 Roger VL, Ballard DJ, Hallett Jr JW, Osmundson PJ, Puetz PA,
Gersh BJ. Inﬂuence of coronary artery disease on morbidity and
mortality after abdominal aortic aneurysmectomy: a population-
based study, 1971e1987. J Am Coll Cardiol 1989;14:1245e52.
5 Hollier LH, Plate G, O’Brien PC, Kazmier FJ, Gloviczki P,
Pairolero PC, et al. Late survival after abdominal aortic aneu-
rysm repair: Inﬂuence of coronary artery disease. J Vasc Surg
1984;1:290e9.
6 McFalls EO, Ward HB, Santilli S, Scheftel M, Chesler E,
Doliszny K. The inﬂuence of peri-operative myocardial infarc-
tion on long-term prognosis following elective vascular surgery.
Chest 1998;113:681e6.
7 Jamieson WR, Janusz MT, Miyagishima RT, Gerein AN. Inﬂuence
of ischaemic heart disease on early and late mortality after
surgery for peripheral occlusive vascular disease. Circulation
1982;66:192e7.
8 Hertzer NR, Beven EG, Young JR, O’Hara PJ,
Ruschhaupt 3rd WF, Graor RA, et al. Coronary artery disease in
peripheral vascular patients: a classiﬁcation of 1000 coronary
angiograms and results of surgical management. Ann Surg
1984;199:223e33.
9 Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA,
Fleischmann KE, et al. ACC/AHA guideline update for peri-
operative cardiovascular evaluation for noncardiac surgery-
executive summary. A report of the American College of Car-
diology/American Heart Association Task Force on Practice
Guidelines (Committee to Update the 1996 Guidelines on Peri-
operative Cardiovascular Evaluation for Noncardiac Surgery).
Anesth Analg 2002;94(5):1052e64.
10 Pierpont GL, Moritz TE, Goldman S, Krupski WC, Littooy F,
Ward HB, et al. Disparate opinions regarding indications for
coronary artery revascularization before elective vascular sur-
gery. Am J Cardiol 2004;94:1124e8.
11 Gottlieb A, Banoub M, Sprung J, Levy PJ, Beven M, Mascha EJ.
Post-operative cardiovascular morbidity in patients with coro-
nary artery disease underscoring vascular surgery after
percutaneous transluminal coronary angioplasty.
J Cardiothorac Vasc Anesth 1998;12:501e6.
12 Brilakis ES, Orford JL, Fasseas P,Wilson SH, Melby S, Lennon RJ,
et al. Outcome of patients undergoing balloon angioplasty in
the two months prior to non-cardiac surgery. Am J Cardiol
2005;96:512e4.
13 Rihal CS, Eagle KA, Mickel MC, Foster ED, Sopko G, Gersh BJ.
Surgical therapy for coronary artery disease among patients
with combined coronary artery and peripheral vascular dis-
ease. Circulation 1995;91:46e53.
14 Abir F, Kakisis I, Sumpio B. Do vascular surgery patients need a
cardiology workup? A review of pre-operative cardiac clear-
ance guidelines in vascular surgery. Eur J Vasc Endovasc Surg
2003;25:110e7.
15 Back MR, Stordahl N, Cuthbertson D, Johnson BL, Bandyk DF.
Limitations in the cardiac risk reduction provided by coronary
revascularization prior to elective vascular surgery. J Vasc Surg
2002;36:526e33.
374 G. Illuminati et al.16 Goessens BM, Visseren FL, Algra A, Banga JD, Van Der Graaf Y.
Screening for asymptomatic cardiovascular disease with non
invasive imaging in patients at high risk and low risk according
to the European guidelines on cardiovascular disease preven-
tion: the SMART study. J Vasc Surg 2006;43:525e32.
17 Illuminati G, Ricco J-B, Greco C, Mangieri E, Calio’ F,
Ceccanei G, et al. Systematic pre-operative coronary angiog-
raphy and stenting improves post-operative results of carotid
endarterectomy in patients with asymptomatic coronary artery
disease: a randomised controlled trial. Eur J Vasc Endovasc
Surg 2010;39:139e45.
18 North American Symptomatic Carotid Endarterectomy Trial
(NASCET) Collaborators. Beneﬁcial effect of carotid endarter-
ectomy in symptomatic patients with high grade carotid ste-
nosis. N Eng J Med 1991;325:445e53.
19 Stone GW, Maehara A, Lansky AJ, De Bruyne B, Cristea E,
Mintz GS, et al. PROSPECT Investigators. A prospective natural-
history study of coronary atherosclerosis. N Engl J Med
2011;364:226e35.
20 Raghunathan A, Rapp JH, Littooy F, Santilli S, Krupski WC,
Ward HB, et al. Post-operative outcomes for patients under-
going elective revascularization for critical ischaemia and
intermittent claudication: a subanalysis of the coronary artery
revascularization prophylaxis (CARP) trial. J Vasc Surg 2006;43:
1175e82.
21 den Dekker MA, van den Dungen JJ, Tielliu IF, Jaspers MM,
Oudkerk M, Vliegenthart R. Prevalence of severe subclinical
coronary artery disease on cardiac CT and MRI in patients with
extra-cardiac arterial disease. Eur J Vasc Endovasc Surg
2013;46:680e9.
22 Poldermans D, Schouten O, Vidakovic R, Bax JJ, Thomson IR,
Hoeks SE, et al. A clinical randomized trial to evaluate the
safety of a non invasive approach in high risk patients under-
going major vascular surgery. The DECREASE-V pilot study. J Am
Coll Cardiol 2007;49:1763e9.
23 Ward HB, Kelly RF, Thottapurathu L, Moritz TE, Larsen GC,
Pierpont G, et al. Coronary artery bypass grafting is superior to
percutaneous coronary intervention in prevention of peri-
operative myocardial infarctions during subsequent vascular
surgery. Ann Thorac Surg 2006;82:795e801.
24 Garcia S, Moritz TE, Ward HB, Pierpont G, Goldman S,
Larsen GC, et al. Usefulness of revascularization of patients
with multivessel coronary artery disease before elective
vascular surgery for abdominal aortic and peripheral occlusive
disease. Am J Cardiol 2008;102:809e13.
25 Bouri S, Shun-Shin MJ, Cole GD, Mayet J, Francis DP. Meta-
analysis of secure randomised controlled trials of beta
blockade to prevent peri-operative death in non-cardiac sur-
gery. Heart 2014;100:456e64.
26 Monaco M, Stassano P, Di Tommaso L, Pepino P, Giordano A,
Pinna GB, et al. Systematic strategy of prophylactic coronary
angiography improves long-term outcome after major vascularsurgery in medium to high risk patients: a prospective ran-
domized study. J Am Coll Cardiol 2009;8:989e96.
27 Landesberg G, Mosseri M. Prophylactic pre-operative coronary
revascularization. Is the Phoenix awakening? J Am Coll Cardiol
2009;54:997e8.
28 Landesberg G, Mosseri M, Wolf YG, Bocher M, Basevotch A,
Rudis E, et al. Pre-operative thallium scanning, selective coro-
nary revascularization, and long-term survival after major
vascular surgery. Circulation 2003;108:177e83.
29 Chung SY, Lee KY, Chun EJ, Lee WW, Park EK, Chang HJ, et al.
Comparison of stress perfusion MRI and SPECT for detection of
myocardial ischaemia in patients with angiographically proven
three-vessel coronary artery disease. AJR Am J Roentgenol
2010;195:356e62.
30 van Waes J, Nathoe HM, de Graaff JC, Kemperman H, de
Borst GJ, Peelen LM, et al. Myocardial injury after noncardiac
surgery and its association with short-term mortality. Circula-
tion 2013;127:2264e71.
31 Simons JP, Baril DT, Goodney PP, Bertges DJ, Robinson WP,
Cronenwett JL, et al. The effect of post-operative myocardial
ischaemia on long-term survival after vascular surgery. J Vasc
Surg 2013;58:1600e8.
32 Prasad A, Gersh BJ, Bertrand ME, Lincoff AM, Moses JW,
Ohman EM, et al. Prognostic signiﬁcance of periprocedural
versus spontaneously occurring myocardial infarction after
percutaneous coronary intervention in patients with acute
coronary syndromes: an analysis from the ACUITY trial. J Am
Coll Cardiol 2009;54:477e86.
33 Halliday A, Mansﬁeld A, Marro J, Peto C, Peto R, Potter J, et al.
MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative
group. Prevention of disabling and fatal strokes by successful
carotid endarterectomy in patients without recent neurological
symptoms: randomised controlled trial. Lancet 2004;363(9420):
1491e502.
34 Halliday A, Harrison M, Hayter E, Kong X, Mansﬁeld A, Marro J,
et al. Asymptomatic Carotid Surgery Trial (ACST) Collaborative
Group. 10-year stroke prevention after successful carotid
endarterectomy for asymptomatic stenosis (ACST-1): a multi-
centre randomised trial. Lancet 2010 25;376(9746):1074e84.
35 Bursi F, Babuin L, Barbieri A, Politi L, ZennaroM, Grimaldi T, et al.
Vascular surgery patients; peri-operative and long-term risk
according to the ACC/AHA guidelines, the additive role of post-
operative troponin elevation. Eur Heart J 2005;26:2448e56.
36 Back MR, Schmacht DC, Bowser AN, Stordahl N, Cuthbertson D,
Johnson BL, et al. Critical appraisal of cardiac risk stratiﬁcation
before elective vascular surgery. Vasc Endovasc Surg 2003;37:
387e97.
37 Psirropoulos D, Efthimiadis A, Boudonas G, Papadopoulos I,
Papadopoulos G, Ekklisiarchos D, et al. Detection of myocardial
ischemia in the elderly versus the young by stress thallium-201
scintigraphy and its relation to important coronary artery dis-
ease. Heart Vessels 2002;16:131e6.
